Price target upside
Jasper Therapeutics, Inc. - Class A Common Stock Price Target Upside or Downside
JSPR price target upside based on the current price and analyst average.
Direct answer
Jasper Therapeutics, Inc. - Class A Common Stock's analyst target implies +1,012.6%.
The average target is $9.17 compared with a recorded current price of $0.82.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 12, 2026.
Get free Jasper Therapeutics, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.82
- Average price target
- $9.17
- High price target
- $20.00
- Low price target
- $1.50
- Target upside
- +1,012.6%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026